<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9010000</journal-id>
<journal-id journal-id-type="pubmed-jr-id">8514</journal-id>
<journal-id journal-id-type="nlm-ta">Curr Opin Lipidol</journal-id>
<journal-id journal-id-type="iso-abbrev">Curr. Opin. Lipidol.</journal-id>
<journal-title-group>
<journal-title>Current opinion in lipidology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0957-9672</issn>
<issn pub-type="epub">1473-6535</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26855231</article-id>
<article-id pub-id-type="pmc">5125441</article-id>
<article-id pub-id-type="doi">10.1097/MOL.0000000000000278</article-id>
<article-id pub-id-type="manuscript">NIHMS831800</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Expanding Role of Gut Microbiota in Lipid Metabolism</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ghazalpour</surname>
<given-names>Anatole</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cespedes</surname>
<given-names>Ivana</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bennett</surname>
<given-names>Brian J.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Allayee</surname>
<given-names>Hooman</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Human Genetics, David Geffen School of Medicine of UCLA, Los Angeles, CA 90095</aff>
<aff id="A2"><label>2</label>Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033</aff>
<aff id="A3"><label>3</label>Institute for Genetic Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033</aff>
<aff id="A4"><label>4</label>Department of Genetics and Nutrition, University of North Carolina, Chapel Hill, NC 27599</aff>
<aff id="A5"><label>5</label>Department of Nutrition Research Institute, University of North Carolina, Chapel Hill, NC 27599</aff>
<author-notes>
<corresp id="cor1"><bold>Address correspondence and reprint requests to:</bold> Hooman Allayee, PhD, Institute for Genetic Medicine, Keck School of Medicine, University of Southern California, 2250 Alcazar Street, CSC202, Los Angeles, CA 90033, Phone: (323) 442-1736, Fax: (332) 442-2764, <email>hallayee@usc.edu</email></corresp>
<fn fn-type="COI-statement" id="FN1">
<p id="P24">
<bold>Conflicts of Interest</bold>
</p>
<p id="P25">None.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>24</day>
<month>11</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>4</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>4</month>
<year>2017</year>
</pub-date>
<volume>27</volume>
<issue>2</issue>
<fpage>141</fpage>
<lpage>147</lpage>
<!--elocation-id from pubmed: 10.1097/MOL.0000000000000278-->
<abstract>
<sec id="S1">
<title>Purpose of review</title>
<p id="P1">This review highlights recent advances in the emerging role that gut microbiota play in modulating metabolic phenotypes, with a particular focus on lipid metabolism.</p>
</sec>
<sec id="S2">
<title>Recent findings</title>
<p id="P2">Accumulating data from both human and animal studies demonstrate that intestinal microbes can affect host lipid metabolism through multiple direct and indirect biological mechanisms. These include a variety of signaling molecules produced by gut bacteria that have potent effects on hepatic lipid and bile metabolism and on reverse cholesterol transport, energy expenditure, and insulin sensitivity in peripheral tissues. Additionally, host genetic factors can modulate the abundance of bacterial taxa, which can subsequently affect various metabolic phenotypes. Proof of causality for identified microbial associations with host lipid-related phenotypes has been demonstrated in several animal studies but remains a challenge in humans. Ultimately, selective manipulation of the gut microbial ecosystem for intervention will first require a better understanding of which specific bacteria, or alternatively, which bacterial metabolites, are appropriate targets.</p>
</sec>
<sec id="S3">
<title>Summary</title>
<p id="P3">Recent discoveries have broad implications for elucidating bacterially-mediated pathophysiological mechanisms that alter lipid metabolism and other related metabolic traits. From a clinical perspective, this newly recognized endocrine organ system can be targeted for therapeutic benefit of dyslipidemia and cardiometabolic diseases.</p>
</sec>
</abstract>
<kwd-group>
<kwd>gut microbiota</kwd>
<kwd>lipid metabolism</kwd>
<kwd>metabolic homeostasis</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>